舒张性心力衰竭患者血清T_3与LVEDP、NT-proBNP、hs-CRP水平的相关性研究被引量：1

导出

摘要目的探讨舒张性心力衰竭患者血清三碘甲腺原氨酸(T_3)与左心室舒张末期压力(LVEDP)、N末端脑力钠肽原(NT-proBNP)、高敏C反应蛋白(hs-CRP)水平的相关性。方法选取诊治的40例舒张性心力衰竭患者(DHF组)及40例同期门诊体检的中老年健康人群(对照组),检测血清T_3、NT-proBNP、hs-CRP水平,超声心电图测定LVEDP,分析结果。结果DHF组患者血清T_3水平低于对照组(P<0.01),LVEDP、NT-proBNP、hs-CRP水平均高于对照组(P<0.01);DHF组心功能III-IV级患者血清T_3水平低于II级患者(P<0.01),LVEDP、NT-proBNP、hs-CRP水平均高于II级患者(P<0.01);pearson相关分析显示DHF患者血清T_3水平越低LVEDP、NT-proBNP、hs-CRP越高,之间呈负相关(P<0.05)。结论 DHF患者血清T_3与LVEDP、NT-proBNP、hs-CRP水平关系密切,并与病情严重程度有关。

作者王峰

机构地区广东省开平市中心医院心内科

出处《白求恩医学杂志》 2017年第3期364-365,共2页 Journal of Bethune Medical Science

关键词心力衰竭三碘甲腺原氨酸左心室舒张末期压力 N末端脑力钠肽原高敏C反应蛋白

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献3

1徐燕,刘遵勇,邵海斌.老年收缩性及舒张性心力衰竭患者血尿酸、C反应蛋白及氨基末端B型利钠肽水平比较[J].中国老年学杂志,2016,36(16):3946-3948. 被引量：9
2刘畅,鞠晨晖,高传玉,王宪沛,麻兴华.舒张性心力衰竭患者血清T3与LVEDP相关性及对预后的影响[J].中国心血管杂志,2016,21(1):32-35. 被引量：5
3丁宇,陈倩,张丽,杨庭树.舒张性心衰患者血清三碘甲状腺原氨酸与脑利钠肽的关系[J].中国误诊学杂志,2010,10(13):3027-3028. 被引量：1

二级参考文献22

1Zile MR,Baicu CF,Gaasch WH. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle [J]. N Engl J Med,2004,350(19):1953-1959.
2VRemme WJ, Swedberg K. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure[J]. Eur Heart ],2001,22(17) :1527-1560.
3Manowitz NR, Mayor GH, Klepper MJ, et al. Subclinical Hypothyroidism and Euthyroid Sick Syndrome in Patients with Moderate to-Severe Congestive Heart Failure [J]. Am J Ther, 1996, 3 (12) :797-801.
4Pingitore A, Landi P, Taddei MC, et al. Triiodothyronine levels for risk stratification of patients with chronic heart failure [J]. Am J Med,2005,118(2):132-136.
5Langton JE, BrentGA. Nonthyroidal illness syndrome: evaluation of thyroid function in sick patients [J]. Endocrinol Metab Clin North Am,2002, 31 (1) :159-172.
6Pinelli M,Bindi M,Cassetti G,et al. Relationship between low T3 syndrome and NT proBNP levels in non cardiac patients [J]. Acta cardio, 2007,62 (1) :19-24.
7Fonarow GC,Stough WG,Abraham WT,et al.Characteristics,treatments,and outcomes of patients with preserved systolic function hospitalized for heart failure:a report from the OPTIMIZE-HF Registry[J].J Am Coll Cardiol,2007,50(8):768-777.DOI:10.1016/j.jacc.2007.04.064.
8Paulus WJ,Tschope C,Sanderson JE,et al.How to diagnose diastolic heart failure:a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology[J].Europ Heart J,2007,28(20):2539-2550.DOI:10.1093/eurheartj/ehm037.
9Silva-Tinoco R,Castillo-Martinez L,Orea-Tejeda A,et al.Developing thyroid disorders is associated with poor prognosis factors in patient with stable chronic heart failure[J].Intern J Cardiol,2011,147(2):e24-25.DOI:10.1016/j.ijcard.2009.01.012.
10Pingitore A,Landi P,Taddei MC,et al.Triiodothyronine levels for risk stratification of patients with chronic heart failure[J].Am J Med,2005,118(2):132-136.DOI:10.1016/j.amjmed.2004.07.052.